Heidi Spratt, PhD, a tenured professor at The University of Texas Medical Branch (UTMB) School of Population and Public Health, has been recognized as a 2026 Fellow of the Association for Clinical and Translational Science (ACTS). ACTS is a nonprofit membership association of translational scientists from the nation’s leading academic medical centers.
Spratt is a collaborative biostatistician with primary interests in bioinformatics, biomarker discovery, predictive modeling, and machine learning. Her research focuses on clinical studies applied to a wide range of disorders, diseases, and populations, including those in the fields of infectious diseases (specifically dengue fever and Chagas disease), liver cancer, internal medicine and geriatrics, and pediatric respiratory infections.
She is a member of the ACTS board of directors and immediate past president of the Association for Clinical and Translational Statisticians (ACTStat). She is also the director of the MS Biostatistics Degree Program at UTMB.
“Being named a 2026 Fellow of ACTS is a real honor, especially in this inaugural cohort,” Spratt said. “ACTS has been an important professional home for me over many years, and I am grateful to be recognized by an organization that has given me valuable opportunities for leadership, mentorship, and collaboration.”
The Fellows of ACTS (FACTS) program was launched this year by ACTS as a premier membership recognizing individuals who have made substantial contributions to the field of clinical and translational science. This inaugural application process was competitive, with 36 individuals selected from almost 6,000 members of ACTS.
"The Fellows of ACTS program recognizes those whose impact on the clinical and translational space and the Association for Clinical and Translational Science is undeniable,” ACTS President Allan R. Brasier said. “The fellowship celebrates the work of the entire translational science community — from researchers to administrative staff.
“These fellows and their contributions truly embody the values and mission of ACTS for innovation, team science, and community. We are pleased to celebrate their achievements and impact at Translational Science 2026.”
ACTS provides a platform for enhancing education, research, and public policy related to clinical and translational science. Members consist of leaders, investigators, and trainees from academic medical centers, government, industry, and philanthropy. ACTS focuses on four realms: research, education, advocacy, and mentoring.